Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses:

Valerio Gristina,Antonio Galvano,L. Castellana,L. Insalaco,Stefania Cusenza,Giuseppa Graceffa,F. Iacono,Nadia Barraco,Marta Castiglia,Alessandro Perez,Sergio Rizzo,Antonio Russo,Viviana Bazan

Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses:

2021

Valerio Gristina
Antonio Galvano
L. Castellana
L. Insalaco
Stefania Cusenza
Giuseppa Graceffa
F. Iacono
Nadia Barraco
Marta Castiglia
Alessandro Perez
Sergio Rizzo
Antonio Russo
Viviana Bazan

Background:The addition of PD-L1 inhibitors to platinum-based chemotherapy (CT) has newly received United States Food and Drug Administration (FDA) approval in extensive stage-small cell lung cance...

Keywords:

chemo immunotherapy
Cell
Extensive-stage small cell lung cancer
food and drug administration
indirect comparison
Internal medicine
Lung
Meta-analysis
Oncology
Chemotherapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations